Joseph Nolan is the founder of Jaguar Gene Therapy. Jaguar Gene Therapy has raised $139M in total funding. Latest round: Series B. Based in Lake Forest, IL.
Joseph Nolan is the Chief Executive Officer of Jaguar Gene Therapy. The company focuses on accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, including galactosemia, genetic causes of autism spectrum disorder, Type 1 diabetes, and Bardet-Biedl syndrome. Jaguar Gene Therapy has raised $139 million in Series B funding.
Full founder directory · Investor directory · Company funding database · Fundraising library